Show simple item record

dc.contributor.authorLegros’, D.
dc.contributor.authorJohnson, K.
dc.contributor.authorHoupikian, P.
dc.contributor.authorMakanga, M.
dc.contributor.authorKabakyenga, J. K.
dc.contributor.authorTalisuna, A. 0.
dc.contributor.authorTaylor, W. R. J.
dc.date.accessioned2024-05-29T12:47:01Z
dc.date.available2024-05-29T12:47:01Z
dc.date.issued2002
dc.identifier.citationLegros, D., Johnson, K., Houpikian, P., Makanga, M., Kabakyenga, J. K., Talisuna, A. O., & Taylor, W. R. J. (2002). Clinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south-western Uganda with uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 96(2), 199-201.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/3689
dc.description.abstractWe conducted a 14-day study (during March- May 1998) to assess the efficacy of chloroquine and sulfadoxine-pyrimethamine (SP) for treating uncomplicated Plasmodium falciparum malaria in Uganda. Overall treatment failure rates were 43 (8 1.1%) of 53 chloroquine recipients and 16 (250%) of 64 SP patients. Strategies to improve the life-span of standard and affordable anti- malarial drugs are needed.en_US
dc.description.sponsorshipMedecins saris Frontiers, France, the French Embassy in Kampala, and the European Development Funden_US
dc.language.isoen_USen_US
dc.publisherTransactions of the Royal Society of Tropical Medicine and Hygieneen_US
dc.subjectMalariaen_US
dc.subjectPlosmodium falciparumen_US
dc.subjectChemo- therapyen_US
dc.subjectChloroquineen_US
dc.subjectSulfadoxine-pyrimethamineen_US
dc.subjectChildrenen_US
dc.subjectEfficacyen_US
dc.subjectUgandaen_US
dc.titleClinical efficacy of chloroquine or sulfadoxine-pyrimethamine in children under five from south- western Uganda with uncomplicated falciparum malariaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record